Pediatrix Medical Group Inc (MD)

$8.24

+0.11

(+1.35%)▲

Market is closed - opens 7 PM, 29 Jul 2024

Performance

  • $8.13
    $8.42
    $8.24
    downward going graph

    1.4%

    Downside

    Day's Volatility :3.5%

    Upside

    2.14%

    downward going graph
  • $6.62
    $15.02
    $8.24
    downward going graph

    19.66%

    Downside

    52 Weeks Volatility :55.93%

    Upside

    45.14%

    downward going graph

Returns

PeriodPediatrix Medical Group IncSector (Health Care)Index (Russel 2000)
3 Months
-10.07%
6.5%
0.0%
6 Months
-17.55%
7.1%
0.0%
1 Year
-43.07%
9.8%
0.0%
3 Years
-72.2%
14.2%
-20.2%

Highlights

Market Capitalization
646.3M
Book Value
$10.36
Earnings Per Share (EPS)
-0.12
PEG Ratio
0.88
Wall Street Target Price
8.21
Profit Margin
-3.53%
Operating Margin TTM
4.92%
Return On Assets TTM
4.24%
Return On Equity TTM
-7.99%
Revenue TTM
2.0B
Revenue Per Share TTM
24.24
Quarterly Revenue Growth YOY
0.8%
Gross Profit TTM
467.0M
EBITDA
189.7M
Diluted Eps TTM
-0.12
Quarterly Earnings Growth YOY
-0.71
EPS Estimate Current Year
1.22
EPS Estimate Next Year
1.3
EPS Estimate Current Quarter
0.19
EPS Estimate Next Quarter
0.35

Analyst Recommendation

Sell
    5%Buy
    47%Hold
    47%Sell
Based on 17 Wall street analysts offering stock ratings for Pediatrix Medical Group Inc(by analysts ranked 0 to 5 stars)
Based on 17 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
1
1
1
Hold
8
8
8
Sell
8
8
8

Analyst Forecast

What analysts predicted

Downside of 0.36%

Current $8.24
Target $8.21

Company Financials

FY18Y/Y Change
Revenue
3.6B
↑ 5.46%
Net Income
268.6M
↓ 16.15%
Net Profit Margin
7.37%
↓ 1.89%
FY19Y/Y Change
Revenue
3.5B
↓ 3.66%
Net Income
-1.2B
↓ 528.13%
Net Profit Margin
-32.73%
↓ 40.1%
FY20Y/Y Change
Revenue
1.7B
↓ 50.65%
Net Income
-9.6M
↓ 99.17%
Net Profit Margin
-0.55%
↑ 32.18%
FY21Y/Y Change
Revenue
1.9B
↑ 10.22%
Net Income
131.0M
↓ 1467.06%
Net Profit Margin
6.85%
↑ 7.4%
FY22Y/Y Change
Revenue
2.0B
↑ 3.18%
Net Income
66.3M
↓ 49.35%
Net Profit Margin
3.36%
↓ 3.49%
FY23Y/Y Change
Revenue
2.0B
↑ 1.15%
Net Income
-60.4M
↓ 191.07%
Net Profit Margin
-3.03%
↓ 6.39%
Q4 FY22Q/Q Change
Revenue
513.8M
↑ 4.88%
Net Income
29.7M
↓ 3.48%
Net Profit Margin
5.77%
↓ 0.5%
Q1 FY23Q/Q Change
Revenue
491.0M
↓ 4.44%
Net Income
14.2M
↓ 52.1%
Net Profit Margin
2.89%
↓ 2.88%
Q2 FY23Q/Q Change
Revenue
500.6M
↑ 1.95%
Net Income
28.3M
↑ 99.08%
Net Profit Margin
5.65%
↑ 2.76%
Q3 FY23Q/Q Change
Revenue
506.6M
↑ 1.21%
Net Income
40.3M
↑ 42.4%
Net Profit Margin
7.95%
↑ 2.3%
Q4 FY23Q/Q Change
Revenue
496.4M
↓ 2.01%
Net Income
-124.3M
↓ 408.61%
Net Profit Margin
-25.04%
↓ 32.99%
Q1 FY24Q/Q Change
Revenue
495.1M
↓ 0.27%
Net Income
4.0M
↓ 103.25%
Net Profit Margin
0.81%
↑ 25.85%
FY18Y/Y Change
Total Assets
5.9B
↑ 1.15%
Total Liabilities
2.8B
↑ 1.65%
FY19Y/Y Change
Total Assets
4.1B
↓ 30.14%
Total Liabilities
2.6B
↓ 7.03%
FY20Y/Y Change
Total Assets
3.3B
↓ 19.25%
Total Liabilities
2.6B
↓ 1.76%
FY21Y/Y Change
Total Assets
2.7B
↓ 18.68%
Total Liabilities
1.8B
↓ 29.78%
FY22Y/Y Change
Total Assets
2.3B
↓ 13.76%
Total Liabilities
1.5B
↓ 20.24%
FY23Y/Y Change
Total Assets
2.2B
↓ 5.45%
Total Liabilities
1.4B
↓ 5.87%
Q4 FY22Q/Q Change
Total Assets
2.3B
↑ 0.68%
Total Liabilities
1.5B
↓ 1.16%
Q1 FY23Q/Q Change
Total Assets
2.3B
↓ 1.19%
Total Liabilities
1.4B
↓ 3.16%
Q2 FY23Q/Q Change
Total Assets
2.3B
↓ 0.63%
Total Liabilities
1.4B
↓ 3.34%
Q3 FY23Q/Q Change
Total Assets
2.3B
↑ 0.9%
Total Liabilities
1.4B
↓ 0.35%
Q4 FY23Q/Q Change
Total Assets
2.2B
↓ 4.58%
Total Liabilities
1.4B
↑ 0.91%
Q1 FY24Q/Q Change
Total Assets
2.2B
↓ 2.33%
Total Liabilities
1.3B
↓ 4.29%
FY18Y/Y Change
Operating Cash Flow
289.9M
↓ 43.31%
Investing Cash Flow
-142.8M
↓ 75.24%
Financing Cash Flow
-170.6M
↓ 290.12%
FY19Y/Y Change
Operating Cash Flow
346.6M
↑ 19.56%
Investing Cash Flow
102.5M
↓ 171.76%
Financing Cash Flow
-393.1M
↑ 130.39%
FY20Y/Y Change
Operating Cash Flow
204.6M
↓ 40.97%
Investing Cash Flow
815.5M
↑ 695.97%
Financing Cash Flow
-4.2M
↓ 98.94%
FY21Y/Y Change
Operating Cash Flow
76.7M
↓ 62.5%
Investing Cash Flow
-53.1M
↓ 106.51%
Financing Cash Flow
-760.1M
↑ 18180.81%
FY22Y/Y Change
Operating Cash Flow
166.9M
↑ 117.55%
Investing Cash Flow
-57.0M
↑ 7.31%
Financing Cash Flow
-487.6M
↓ 35.86%
Q4 FY22Q/Q Change
Operating Cash Flow
98.7M
↑ 18.43%
Investing Cash Flow
-11.2M
↑ 84.64%
Financing Cash Flow
-86.3M
↑ 4.39%
Q1 FY23Q/Q Change
Operating Cash Flow
-100.9M
↓ 202.26%
Investing Cash Flow
-11.4M
↑ 0.97%
Financing Cash Flow
108.6M
↓ 225.82%
Q2 FY23Q/Q Change
Operating Cash Flow
89.1M
↓ 188.24%
Investing Cash Flow
-21.7M
↑ 91.61%
Financing Cash Flow
-78.9M
↓ 172.7%
Q3 FY23Q/Q Change
Operating Cash Flow
79.9M
↓ 10.24%
Investing Cash Flow
-35.8M
↑ 64.39%
Financing Cash Flow
-50.6M
↓ 35.89%

Technicals Summary

Sell

Neutral

Buy

Pediatrix Medical Group Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Pediatrix Medical Group Inc
Pediatrix Medical Group Inc
5.58%
-17.55%
-43.07%
-72.2%
-65.9%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
6.75%
1.59%
-22.77%
-49.63%
-45.76%
Hca Holdings, Inc.
Hca Holdings, Inc.
3.62%
24.47%
25.02%
43.55%
143.2%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
10.35%
80.65%
95.1%
108.93%
580.33%
Universal Health Services Inc.
Universal Health Services Inc.
8.08%
30.09%
44.94%
32.59%
34.96%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
0.24%
32.97%
40.81%
19.01%
139.9%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Pediatrix Medical Group Inc
Pediatrix Medical Group Inc
0.0
NA
0.88
1.22
-0.08
0.04
NA
10.36
Fresenius Medical Care Ag
Fresenius Medical Care Ag
22.58
22.58
0.39
1.5
0.05
0.03
0.03
47.4
Hca Holdings, Inc.
Hca Holdings, Inc.
16.16
16.16
1.44
21.86
0.74
0.11
0.01
-6.06
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
5.46
5.46
1.74
8.98
0.54
0.07
NA
16.09
Universal Health Services Inc.
Universal Health Services Inc.
15.8
15.8
1.87
13.79
0.13
0.06
0.0
93.48
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
16.31
16.31
1.16
9.32
0.43
0.06
NA
10.56
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Pediatrix Medical Group Inc
Pediatrix Medical Group Inc
Sell
$646.3M
-65.9%
0.0
-3.53%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
Hold
$11.9B
-45.76%
22.58
2.48%
Hca Holdings, Inc.
Hca Holdings, Inc.
Buy
$90.1B
143.2%
16.16
8.4%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
Buy
$14.6B
580.33%
5.46
12.54%
Universal Health Services Inc.
Universal Health Services Inc.
Hold
$12.4B
34.96%
15.8
5.57%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
Hold
$12.6B
139.9%
16.31
6.61%

Insights on Pediatrix Medical Group Inc

  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 506.61M → 495.10M (in $), with an average decrease of 1.1% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -124.28M → 4.03M (in $), with an average increase of 3180.2% per quarter

  • Vs THC

    In the last 1 year, Tenet Healthcare Corp.  has given 95.1% return, outperforming this stock by 138.2%

  • Vs THC

    In the last 3 years, Tenet Healthcare Corp.  has given 108.9% return, outperforming this stock by 181.1%

Institutional Holdings

  • BlackRock Inc

    16.10%

  • Vanguard Group Inc

    12.55%

  • AllianceBernstein L.P.

    9.61%

  • Earnest Partners LLC

    5.69%

  • Dimensional Fund Advisors, Inc.

    4.77%

  • State Street Corporation

    4.02%

Company Information

mednax is a physician-led health solutions partner providing the highest quality patient care through our national network of nearly 3,000 physicians. our physician practices and business professionals are passionate about taking great care of patients, continually optimizing performance and helping providers overcome healthcare’s quality, financial and administrative complexities. physicians and advanced practitioners practicing as part of mednax are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives, clinical research to enhance patient outcomes and provide high-quality, cost-effective care. the company was founded in 1979, and today, through its affiliated professional corporations, mednax provides services through a network of more than 3,200 physicians in all 50 states and puerto rico. in addition to its national physician network, mednax provides services to healthcare facilities and physicians in

Organization
Pediatrix Medical Group Inc
Employees
5450
CEO
Dr. James D. Swift M.D.
Industry
Health Services

Discover More

FAQs